Acute Leukemia Perspective

 
 
  • Our Failures Demand a New Approach to Cancer Given the slow progress of the 'War on Cancer,' do we really expect that pouring ever-increasing amounts of money into the current treatment paradigm will provide a real solution?
  • ASH 2019 Read clinically focused news coverage of key developments from ASH 2019
  • New Options in Adult AML   Duke oncologists discuss expanded treatment options for older AML patients, including numerous targeted therapies and less intensive regimens that yield durable remissions and improve quality of life.
  • EHA 2019 Read clinically focused news coverage of key developments from EHA 2019
  • BSH 2019 Read clinically focused news coverage of key developments from BSH 2019
  • EBMT 2019 Read clinically focused news coverage of key developments from EBMT 2019
  • Are We Relying Too Much on Biomarkers and Algorithms? In the age of biomarker-based risk assessment, oncologist Ravi Parikh gets 'a sobering lesson in what really matters when we talk about prognosis in oncology.'
  • TCT 2019 Read clinically focused news coverage of key developments from TCT 2019
  • CAR T Cell Therapy: 'It's the Real World Now'   Drs Jacobson, Miklos, and Maus unveil 'provocative and exciting' research at ASH 2018 in CAR T cell therapy.
  • ASH 2018: 'Amazing Developments' in AML Treatment   Jorge Cortes highlights the most promising data on new drugs and drug combinations for treatment of AML.
  • NCI Director Promises New Directions to Accelerate Route to Cure Dr Norman Sharpless, director of the National Cancer Institute, provides an update on the progress of cancer research in the United States, and his goals for the future.
  • Top News From ASH 2018: Slideshow Hot topics include practice change data on chronic lymphocytic leukemia, validation of the durability of CAR T cells, and a new standard of care in myeloma.
  • Hard Lessons From Year 1 of Oncology Fellowship Loss of autonomy. Practicing in areas of medicine without good evidence. Providing end-of-life care. Oncology fellowship comes with its own unique set of tough lessons.
  • Medscape Physicians' Choice: Top Hospitals for Cancer Treatment Medscape surveyed more than 11,000 physicians to get their opinions on which hospitals they'd send family members to in order to have serious and complex cancer cases treated.
  • Immunotherapy Combinations Show Promise for Blood Cancers Immunotherapy combinations hold great promise for treating hematologic cancers, but the approach is not without risk.
  • Training 'Front-line' Staff to Manage CAR T Toxicity Is Critical Experts outline strategies for managing CAR T-cell toxicity outside of clinical trials.
  • Acute Myeloid Leukemia Overview Video   This video discusses the pathophysiology and major clinical signs and symptoms of acute myeloid leukemia.
  • 'Real World' CAR T Cells: Comparing and Using Approved Products   Drs Perales and Pasquini discuss the rapidly advancing field of CAR T and how patient safety and choice can be managed during these unprecedented times.
  • Maximizing Response in Acute Leukemia: Pearls From ASH 2017   Drs Cortes and DeAngelo highlight the most intriguing clinical trials presented in the field of leukemia at ASH 2017.
  • Eric Topol's Top 10 Tech Advances Shaping Medicine Dr Eric Topol identifies the latest tech advances in medicine that set the stage for the coming year.